Jinan Hongjitang Pharmaceutical Co., Ltd. was founded in 1907, which is one of the 21 key Chinese medicine enterprises and one of the top 50 Chinese medicine enterprises in China with the right to import and export, with a history of more than one hundred years.In 1991, the company was honored as a high-tech enterprise in Shandong Province, and was honored as a "Chinese Old Famous Trademark" enterprise by the Ministry of Domestic Trade of China in 1995. In 1995, the company was honored as "Chinese Old Brand" by the Ministry of Domestic Trade of China. The company has been through Hongjitang, Hongji Pharmaceutical Factory, Jinan People's Pharmaceutical Factory, Shandong Jinan Traditional Chinese Medicine Factory and other changes, in 1999 by the Shandong Jinan Traditional Chinese Medicine Factory restructuring Jinan Hongjitang Pharmaceutical Limited Liability Company, in October 2002 in accordance with the "combination of strength, complement each other's strengths, resources * * * enjoy, * * * with the development of the principle of "integration, integration, integration, and become a Linuo Group In October 2002, according to the principle of "Strength Combination, Complementary Advantages, Resource ***Hanging, ***Same Development", it was integrated with Linuo Group and became the core enterprise of Linuo Group. The company is one of the 40 big profit tax payers in Jinan city, famous enterprise in Shandong province and advanced unit of spiritual civilization in Shandong province. The company's "Prostaxin Capsules" and "Children's Anti-Food Tablets" have become China's famous brand products.
Jinan Hongjitang Pharmaceutical Co., Ltd. is located at No. 360, Hualong Road, Jinan Hi-Tech Industrial Development Zone, covering an area of 102 acres, with a total construction area of 45,000 square meters and an investment of 170 million yuan, and has passed the GMP certification in December 2003 in China. Among them, the pre-treatment workshop has a floor area of 8,600 square meters, with an annual capacity of 4,000 tons of Chinese herbal medicines. The extraction workshop has a floor area of 6,500 square meters, with an annual extraction capacity of 2,000 tons of raw herbs and 2,000 tons of powder, and adopts advanced technology and equipment such as dynamic extraction, double-effect concentration, spray granulation and ultra-fine pulverization in each process, and adopts automatic control of microcomputer in the whole production process. The preparation workshop has a construction area of 16,600 square meters, including a purification area of 5,400 square meters, which can produce 11 dosage forms such as tablets, capsules, granules, oral liquid, honey pills, etc. The annual production capacity of the company is 3 billion tablets, 500 million capsules and 10 million bags of granules. The fully automatic air-conditioning system ensures that the production environment is in the best controlled state. There is also a fully automated three-dimensional warehouse. Extraction and preparation workshops are rationally laid out, with advanced equipment and high automation level, which are in a leading position in China. The quality of the products is higher than the Chinese National Pharmacopoeia and ministerial standards. The workshop of musk ketone, the first class new drug of China, has a building area of 4300 square meters, advanced equipment and leading technology, with an annual output of 300kg of musk ketone, which is a high-tech and high value-added product of China, and is the largest musk ketone production base in Asia and the only one in China. Jinan Hongjitang Pharmaceutical Co., Ltd. adheres to the people-oriented, science and technology development, has a strong science and technology team. Jinan Institute of Traditional Chinese Medicine is the subordinate scientific research unit of Hongjitang Pharmaceutical Company, more than 95% of the scientific researchers are postgraduates and undergraduates, and has established the system of production, study and research with famous Chinese universities, new scientific research results are launched every year, and there are 27 new medicines of national Class I, Class II and Class III being developed. On Dec. 23, 2004, "Musk Heartburn Ning" was awarded the certificate of China's third class new drug of Chinese medicine. Six products under research and development are under clinical testing, establishing a product structure system of producing and selling one generation, reserving one generation and developing one generation. The company has 11 major dosage forms of 140 products of national drug [approved], of which China's national class I new drug artificial musk ketone has been designated as a national high-tech products, with broad market prospects. The three national new drugs are Prostaxin Capsule, Musk Heartache Tablet, Jinming Tablet, etc.; 3 products of Coronary Heart Suho Pill, Dendrobium Nightshade Pill and Six-flavored Dihuang Pill have been awarded the Silver Prize of China; 6 products of Laryngeal Symptoms Pill, Compound Cassia Antidotes Tablet, Daifengjing, Hailong Clam and Mealybug Oral Liquid, Infant's An Tablet, Yinqiao Antidote Pill have been awarded the title of Ministry of Excellence and Provincial Excellence; and 6 products of Children's Anti-feeding Tablet, Jinming Tablet, Prostaxin Capsule, Hailong Clam and Mealybug Oral Liquid, Anti-bacteria Anti-inflammatory tablets, Xiongbian heart pills, anti-embolism pills, compound antelope antidote tablets 8 products for China's national protection of traditional Chinese medicine varieties; prostate Xin capsule, sea dragon mealybugs oral solution through the U.S. FDA certification.
Jinan Hongjitang Pharmaceutical Co., Ltd. has a sound marketing network, and its sales network covers all regions in China except Tibet and Taiwan. The international market radiates Southeast Asia, the United States, Russia, Europe*** body and other countries and regions. At the same time, Hongjitang is actively involved in retail pharmacies, with 10 chain pharmacies, one-time through the Chinese national GSP certification. Through the advantages of brand name, product quality, market network, service and continuous innovation, Hongjitang has realized the rapid growth of market share and healthy and sustainable development, and the newly listed "Fengshatou" for rheumatism and "Xinbaokang" for cardio-cerebral vascular disease in 2005 have achieved the rapid growth and healthy and sustainable development. "With its strong market network and unique therapeutic effects, the company has rapidly captured the market.
Jinan Hongjitang Pharmaceutical Co., Ltd. is taking the modernization concept of "innovation and change in pursuit of excellence", fully implementing the development strategy of brand, scale and efficiency, and making every effort to move towards the goal of specialization, modernization and internationalization of traditional Chinese medicine.